Wednesday, July 3, 2024

Highlights of the 2024 European Stroke Organization Conference

 Look at that! NOTHING ON GETTING SURVIVORS RECOVERED! You would think with stroke in the name, it would be about helping stroke survivors! 22 minute podcast, I'm not listening.

Highlights of the 2024 European Stroke Organization Conference

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference.

Show references: 

Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy 

Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III)

Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE)

Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.

Andrew M. Southerland, MD, MSc, FAHA, FAAN

Editorial Board, Neurology® Education

Andrew M. Southerland is a Harrison Distinguished Teaching Professor of Neurology and Public Health Sciences at the University of Virginia. He received his M.D. as a Brody Scholar from the Brody School of Medicine at East Carolina University, and completed his Neurology Residency and Vascular Neurology Fellowship at the University of Virginia. He currently serves as Residency Program Director and Executive Vice Chair in the UVA Department of Neurology. Dr. Southerland also serves on the AAN Education Committee and the Editorial Board for Neurology: Education.

Seemant Chaturvedi, MD, FAAN, FAHA

Editorial Board, Neurology®

No comments:

Post a Comment